ProCE Banner Activity

Expert Treatment Guidance for Myelodysplastic Syndromes


Use this Interactive Decision Support Tool to compare your approach for treating patients with myelodysplastic syndromes with the strategies recommended by 5 renowned experts.

Released: May 09, 2022

Expiration: May 08, 2023

Begin Activity



Rami S. Komrokji

Rami S. Komrokji, MD

Professor of Oncologic Sciences
Department of Oncologic Sciences
University of Florida
Senior Member/Clinical Director
Malignant Hematology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

Suzanne Ameringer

Suzanne Ameringer, PhD, RN

Assistant Professor
Family and Community Health Nursing
Virginia Commonwealth University
Richmond, Virginia

Danielle M. Brander

Danielle M. Brander, MD

Medical Instructor
Division of Hematologic Malignancies & Cellular Therapy
Department of Medicine
Duke University
Attending Physician, Hematologic Malignancies
Duke University Health System
Durham, North Carolina

Amy Carlson

Amy Carlson,

Hospitalist/Lead APP
Northwest Medical Center
American Physician Partners for the Tucson Market
Tucson, Arizona

Carter Michael

Carter Michael,

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Supported by educational grants from



Gilead Sciences, Inc.

Novartis Pharmaceuticals Corporation

Taiho Oncology Inc

Additional Information

Program Medium

This program has been made available online.